| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CareDx, Inc. | Director | Common Stock | 143K | $2.21M | $15.42 | Jun 14, 2024 | Direct |
| Intellia Therapeutics, Inc. | Director | Common Stock | 49.5K | $1.63M | $32.99 | Jun 12, 2024 | Direct |
| Progyny, Inc. | Director | Common Stock | 22.7K | $725K | $31.95 | May 23, 2024 | Direct |
| CareDx, Inc. | Director | Stock Option (right to buy) | 16K | $84.6K | $5.27 | Jun 14, 2024 | Direct |
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 4.52M | Feb 12, 2024 | Indirect | ||
| Progyny, Inc. | Director | Stock Option (Right to Buy) | 25.1K | May 23, 2024 | Direct | ||
| Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 11.5K | Jun 12, 2024 | Direct | ||
| UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10K | Aug 6, 2024 | Direct | ||
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Series A-1 Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Series A-2 Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
| Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Aug 6, 2024 | 1 | $0 | 4 | Aug 8, 2024 | Director |
| CDNA | CareDx, Inc. | Jun 14, 2024 | 1 | $0 | 4/A | Jun 20, 2024 | Director |
| CDNA | CareDx, Inc. | Jun 14, 2024 | 2 | $0 | 4 | Jun 18, 2024 | Director |
| NTLA | Intellia Therapeutics, Inc. | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
| PGNY | Progyny, Inc. | May 23, 2024 | 2 | $0 | 4 | May 28, 2024 | Director |
| KYTX | Kyverna Therapeutics, Inc. | Feb 12, 2024 | 4 | $0 | 4 | Feb 14, 2024 | Director, 10%+ Owner |
| KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | Director, 10%+ Owner |
| URGN | UroGen Pharma Ltd. | Sep 7, 2023 | 1 | $0 | 4 | Sep 8, 2023 | Director |
| URGN | UroGen Pharma Ltd. | Jul 26, 2023 | 1 | $661K | 4 | Jul 28, 2023 | Director |
| CDNA | CareDx, Inc. | Jun 16, 2023 | 2 | $0 | 4 | Jun 21, 2023 | Director |
| NTLA | Intellia Therapeutics, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| PGNY | Progyny, Inc. | May 24, 2023 | 2 | $0 | 4 | May 26, 2023 | Director |
| CDNA | CareDx, Inc. | Jan 6, 2023 | 1 | $0 | 4 | Jan 9, 2023 | Director |
| PGNY | Progyny, Inc. | Oct 24, 2022 | 3 | $0 | 4 | Oct 26, 2022 | Director |
| CDNA | CareDx, Inc. | Oct 4, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
| CDNA | CareDx, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
| NTLA | Intellia Therapeutics, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
| URGN | UroGen Pharma Ltd. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| PGNY | Progyny, Inc. | Oct 24, 2021 | 2 | $0 | 4 | Oct 26, 2021 | Director |
| NTLA | Intellia Therapeutics, Inc. | Jun 23, 2021 | 2 | $0 | 4 | Jun 25, 2021 | Director |
| CDNA | CareDx, Inc. | Jun 16, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
| URGN | UroGen Pharma Ltd. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |